ArticleClinical ophthalmology (Auckland, N.Z.)2025

Aganirsen as a Therapeutic Alternative for Modulating Corneal Neovascularization: A Real-World Case Series Study.

Salvador García-Delpech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.